ArticleFrontiers in oncology2026

Two-year dynamic risk stratification and adjuvant radioiodine efficacy in initial non-distant metastatic papillary thyroid carcinoma harboring TERT promoter mutations.

Xian-Zhao Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.